From lab coat to deal sheet: celebrating Michael Kakanis’ journey to Director

17.9.2024

We’re thrilled to announce the promotion of Michael Kakanis to Director at InterFinancial and his recent appointment as Co-Chair of Healthcare at Clairfield International.  

Michael’s journey is nothing short of inspiring. Working as a lecturer in Physiology and Biochemistry while completing his PhD in Immunology, Michael was all set for a long career in Academia. But in 2017, he took a leap of faith and left behind a promising career in science to explore the dynamic financial industry. Along with a CFA Level 1 under his belt, Michael was determined to get his foot in the door.  

After countless coffee catch-ups and a fair share of setbacks, Michael’s persistence paid off when our Executive Chair, Sharon Doyle offered him a 10-day internship. This opportunity quickly translated into a part-time analyst position, and from there, Michael’s career path took off.  

Since then, Michael has been lucky to work across various sectors, both on the buy-side and sell-side, including financial services, defence, IT services & software, professional & engineering services, mining technology & services. However, it is in the health services and technology space that Michael has truly found his niche. His expertise in M&A over the years has seen him drive some key deals at InterFinancial, such as: 

  • Alliance Automation: Michael achieved an exceptional outcome for the client while navigating the challenges of the COVID-19 pandemic.  
  • National Veterinary Care: Michael’s first public-to-private deal saw him deliver outstanding results while collaborating with a fantastic team.  
  • Microba: A cross-border buy-side deal with a strong scientific core in a rapidly emerging field, a space where Michael’s passion lies. 

Please join us once again to congratulate Michael on his well-deserved promotion and recognition. We are proud to have him on the team and represent us on a global stage at Clairfield International. He’s truly an inspiration to all of us at InterFinancial! 

27.2.2026

Sector dashboards February 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.2.2026

On the floor at EvokeAg 2026: Luke Harwood’s reflections on Australian Agtech

EvokeAg 2026 drew over 1,500 delegates from 18 countries to Melbourne in February, with the Federal Government committing another $450,000 to support the event over the next three years. The visible momentum is real, and the cohort of companies I spent two days meeting reflected it. Most were past proof-of-concept by a meaningful margin, with […]

Read more
27.2.2026

Australian mining industry: Outlook, drivers and opportunities for METS companies

The Australian mining industry enters 2026 with a constructive, albeit moderating, outlook shaped by global economic conditions and the structural shift toward decarbonisation. The Australian Government’s Office of the Chief Economist, in its latest Resources and Energy Quarterly, notes that commodity prices are generally expected to ease from recent highs but remain supportive of continued […]

Read more
28.1.2026

Sector dashboards January 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.1.2026

What has 2025 taught us about APAC M&A and what comes next in 2026?

As we kick off the new year, we went around the InterFinancial team and asked a simple question: What did you see in the APAC M&A market in 2025, and what does it mean for 2026?  The answers were candid, thoughtful and in some cases, refreshingly blunt. While the headlines were dominated by AI hype, geopolitical noise and regulatory change, the […]

Read more
16.12.2025

Sector dashboards December 2025

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.11.2025

Sector dashboards November 2025

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.11.2025

APAC Tech M&A: What Q3 trends mean for Aussie sellers? 

MergerMarket and DataSite have released their Asia Pacific Q3 M&A report and it’s full of insights for technology founders thinking about an exit in the next few years. While activity has slowed from previous highs, tech is still the most active sector across the region, and the pipeline of companies preparing for sale remains deep. […]

Read more
28.10.2025

Sector dashboards October 2025

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more